The Bellagio report

Cardiovascular risks of spaceflight: Implications for the future of space travel

Marian B. Sides, Joan Vernikos, Victor A. Convertino, Jan Stepanek, Lloyd D. Tripp, Jorg Draeger, Alan R. Hargens, Chrysoula Kourtidou-Papadeli, Anne Pavy-LeTraon, Thais Russomano, Julielynn Y. Wong, Regina R. Buccello, Peter H. Lee, Vishal Nangalia, M. Joan Saary

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Long-duration space missions, as well as emerging civilian tourist space travel activities, prompted review and assessment of data available to date focusing on cardiovascular risk and available risk mitigation strategies. The goal was the creation of tools for risk priority assessments taking into account the probability of the occurrence of an adverse cardiovascular event and available and published literature from spaceflight data as well as available risk mitigation strategies. Methods: An international group of scientists convened in Bellagio, Italy, in 2004 under the auspices of the Aerospace Medical Association to review available literature for cardiac risks identified in the Bioastronautics Critical Path Roadmap (versions 2000, 2004). This effort led to the creation of a priority assessment framework to allow for an objective assessment of the hazard, probability of its occurrence, mission impact, and available risk mitigation measures. Results/Conclusions: Spaceflight data are presented regarding evidence/no evidence of cardiac dysrhythmias, cardiovascular disease, and cardiac function as well as orthostatic intolerance, exercise capacity, and peripheral resistance in presyncopal astronauts compared to non-presyncopal astronauts. Assessment of the priority of different countermeasures was achieved with a tabular framework with focus on probability of occurrence, mission impact, compliance, practicality, and effectiveness of countermeasures. Special operational settings and circumstances related to sensitive portions of any mission and the impact of environmental influences on mission effectiveness are addressed. The need for development of diagnostic tools, techniques, and countermeasure devices, food preparation, preservation technologies and medication, as well as an infrastructure to support these operations are stressed. Selected countermeasure options, including artificial gravity and pharmacological countermeasures need to be systematically evaluated and validated in flight, especially after long-duration exposures. Data need to be collected regarding the emerging field of suborbital and orbital civilian space travel, to allow for sound risk assessment. Reprint &

Original languageEnglish (US)
Pages (from-to)877-895
Number of pages19
JournalAviation Space and Environmental Medicine
Volume76
Issue number9
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Space Flight
Astronauts
Risk assessment
Altered Gravity
Orthostatic Intolerance
Food Preservation
Critical Pathways
Vascular Resistance
Italy
Compliance
Cardiac Arrhythmias
Hazards
Gravitation
Cardiovascular Diseases
Acoustic waves
Pharmacology
Exercise
Technology
Equipment and Supplies

Keywords

  • Cardiovascular risks
  • Countermeasures
  • Diagnostics
  • Medical care
  • Monitoring
  • Population characteristics
  • Technology development

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Pollution
  • Medicine(all)

Cite this

Sides, M. B., Vernikos, J., Convertino, V. A., Stepanek, J., Tripp, L. D., Draeger, J., ... Saary, M. J. (2005). The Bellagio report: Cardiovascular risks of spaceflight: Implications for the future of space travel. Aviation Space and Environmental Medicine, 76(9), 877-895.

The Bellagio report : Cardiovascular risks of spaceflight: Implications for the future of space travel. / Sides, Marian B.; Vernikos, Joan; Convertino, Victor A.; Stepanek, Jan; Tripp, Lloyd D.; Draeger, Jorg; Hargens, Alan R.; Kourtidou-Papadeli, Chrysoula; Pavy-LeTraon, Anne; Russomano, Thais; Wong, Julielynn Y.; Buccello, Regina R.; Lee, Peter H.; Nangalia, Vishal; Saary, M. Joan.

In: Aviation Space and Environmental Medicine, Vol. 76, No. 9, 09.2005, p. 877-895.

Research output: Contribution to journalArticle

Sides, MB, Vernikos, J, Convertino, VA, Stepanek, J, Tripp, LD, Draeger, J, Hargens, AR, Kourtidou-Papadeli, C, Pavy-LeTraon, A, Russomano, T, Wong, JY, Buccello, RR, Lee, PH, Nangalia, V & Saary, MJ 2005, 'The Bellagio report: Cardiovascular risks of spaceflight: Implications for the future of space travel', Aviation Space and Environmental Medicine, vol. 76, no. 9, pp. 877-895.
Sides MB, Vernikos J, Convertino VA, Stepanek J, Tripp LD, Draeger J et al. The Bellagio report: Cardiovascular risks of spaceflight: Implications for the future of space travel. Aviation Space and Environmental Medicine. 2005 Sep;76(9):877-895.
Sides, Marian B. ; Vernikos, Joan ; Convertino, Victor A. ; Stepanek, Jan ; Tripp, Lloyd D. ; Draeger, Jorg ; Hargens, Alan R. ; Kourtidou-Papadeli, Chrysoula ; Pavy-LeTraon, Anne ; Russomano, Thais ; Wong, Julielynn Y. ; Buccello, Regina R. ; Lee, Peter H. ; Nangalia, Vishal ; Saary, M. Joan. / The Bellagio report : Cardiovascular risks of spaceflight: Implications for the future of space travel. In: Aviation Space and Environmental Medicine. 2005 ; Vol. 76, No. 9. pp. 877-895.
@article{49fde4bb3cad447fbbd1c2c17cd89b66,
title = "The Bellagio report: Cardiovascular risks of spaceflight: Implications for the future of space travel",
abstract = "Background: Long-duration space missions, as well as emerging civilian tourist space travel activities, prompted review and assessment of data available to date focusing on cardiovascular risk and available risk mitigation strategies. The goal was the creation of tools for risk priority assessments taking into account the probability of the occurrence of an adverse cardiovascular event and available and published literature from spaceflight data as well as available risk mitigation strategies. Methods: An international group of scientists convened in Bellagio, Italy, in 2004 under the auspices of the Aerospace Medical Association to review available literature for cardiac risks identified in the Bioastronautics Critical Path Roadmap (versions 2000, 2004). This effort led to the creation of a priority assessment framework to allow for an objective assessment of the hazard, probability of its occurrence, mission impact, and available risk mitigation measures. Results/Conclusions: Spaceflight data are presented regarding evidence/no evidence of cardiac dysrhythmias, cardiovascular disease, and cardiac function as well as orthostatic intolerance, exercise capacity, and peripheral resistance in presyncopal astronauts compared to non-presyncopal astronauts. Assessment of the priority of different countermeasures was achieved with a tabular framework with focus on probability of occurrence, mission impact, compliance, practicality, and effectiveness of countermeasures. Special operational settings and circumstances related to sensitive portions of any mission and the impact of environmental influences on mission effectiveness are addressed. The need for development of diagnostic tools, techniques, and countermeasure devices, food preparation, preservation technologies and medication, as well as an infrastructure to support these operations are stressed. Selected countermeasure options, including artificial gravity and pharmacological countermeasures need to be systematically evaluated and validated in flight, especially after long-duration exposures. Data need to be collected regarding the emerging field of suborbital and orbital civilian space travel, to allow for sound risk assessment. Reprint &",
keywords = "Cardiovascular risks, Countermeasures, Diagnostics, Medical care, Monitoring, Population characteristics, Technology development",
author = "Sides, {Marian B.} and Joan Vernikos and Convertino, {Victor A.} and Jan Stepanek and Tripp, {Lloyd D.} and Jorg Draeger and Hargens, {Alan R.} and Chrysoula Kourtidou-Papadeli and Anne Pavy-LeTraon and Thais Russomano and Wong, {Julielynn Y.} and Buccello, {Regina R.} and Lee, {Peter H.} and Vishal Nangalia and Saary, {M. Joan}",
year = "2005",
month = "9",
language = "English (US)",
volume = "76",
pages = "877--895",
journal = "Aerospace medicine and human performance",
issn = "2375-6314",
publisher = "Aerospace Medical Association",
number = "9",

}

TY - JOUR

T1 - The Bellagio report

T2 - Cardiovascular risks of spaceflight: Implications for the future of space travel

AU - Sides, Marian B.

AU - Vernikos, Joan

AU - Convertino, Victor A.

AU - Stepanek, Jan

AU - Tripp, Lloyd D.

AU - Draeger, Jorg

AU - Hargens, Alan R.

AU - Kourtidou-Papadeli, Chrysoula

AU - Pavy-LeTraon, Anne

AU - Russomano, Thais

AU - Wong, Julielynn Y.

AU - Buccello, Regina R.

AU - Lee, Peter H.

AU - Nangalia, Vishal

AU - Saary, M. Joan

PY - 2005/9

Y1 - 2005/9

N2 - Background: Long-duration space missions, as well as emerging civilian tourist space travel activities, prompted review and assessment of data available to date focusing on cardiovascular risk and available risk mitigation strategies. The goal was the creation of tools for risk priority assessments taking into account the probability of the occurrence of an adverse cardiovascular event and available and published literature from spaceflight data as well as available risk mitigation strategies. Methods: An international group of scientists convened in Bellagio, Italy, in 2004 under the auspices of the Aerospace Medical Association to review available literature for cardiac risks identified in the Bioastronautics Critical Path Roadmap (versions 2000, 2004). This effort led to the creation of a priority assessment framework to allow for an objective assessment of the hazard, probability of its occurrence, mission impact, and available risk mitigation measures. Results/Conclusions: Spaceflight data are presented regarding evidence/no evidence of cardiac dysrhythmias, cardiovascular disease, and cardiac function as well as orthostatic intolerance, exercise capacity, and peripheral resistance in presyncopal astronauts compared to non-presyncopal astronauts. Assessment of the priority of different countermeasures was achieved with a tabular framework with focus on probability of occurrence, mission impact, compliance, practicality, and effectiveness of countermeasures. Special operational settings and circumstances related to sensitive portions of any mission and the impact of environmental influences on mission effectiveness are addressed. The need for development of diagnostic tools, techniques, and countermeasure devices, food preparation, preservation technologies and medication, as well as an infrastructure to support these operations are stressed. Selected countermeasure options, including artificial gravity and pharmacological countermeasures need to be systematically evaluated and validated in flight, especially after long-duration exposures. Data need to be collected regarding the emerging field of suborbital and orbital civilian space travel, to allow for sound risk assessment. Reprint &

AB - Background: Long-duration space missions, as well as emerging civilian tourist space travel activities, prompted review and assessment of data available to date focusing on cardiovascular risk and available risk mitigation strategies. The goal was the creation of tools for risk priority assessments taking into account the probability of the occurrence of an adverse cardiovascular event and available and published literature from spaceflight data as well as available risk mitigation strategies. Methods: An international group of scientists convened in Bellagio, Italy, in 2004 under the auspices of the Aerospace Medical Association to review available literature for cardiac risks identified in the Bioastronautics Critical Path Roadmap (versions 2000, 2004). This effort led to the creation of a priority assessment framework to allow for an objective assessment of the hazard, probability of its occurrence, mission impact, and available risk mitigation measures. Results/Conclusions: Spaceflight data are presented regarding evidence/no evidence of cardiac dysrhythmias, cardiovascular disease, and cardiac function as well as orthostatic intolerance, exercise capacity, and peripheral resistance in presyncopal astronauts compared to non-presyncopal astronauts. Assessment of the priority of different countermeasures was achieved with a tabular framework with focus on probability of occurrence, mission impact, compliance, practicality, and effectiveness of countermeasures. Special operational settings and circumstances related to sensitive portions of any mission and the impact of environmental influences on mission effectiveness are addressed. The need for development of diagnostic tools, techniques, and countermeasure devices, food preparation, preservation technologies and medication, as well as an infrastructure to support these operations are stressed. Selected countermeasure options, including artificial gravity and pharmacological countermeasures need to be systematically evaluated and validated in flight, especially after long-duration exposures. Data need to be collected regarding the emerging field of suborbital and orbital civilian space travel, to allow for sound risk assessment. Reprint &

KW - Cardiovascular risks

KW - Countermeasures

KW - Diagnostics

KW - Medical care

KW - Monitoring

KW - Population characteristics

KW - Technology development

UR - http://www.scopus.com/inward/record.url?scp=24644501157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644501157&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 877

EP - 895

JO - Aerospace medicine and human performance

JF - Aerospace medicine and human performance

SN - 2375-6314

IS - 9

ER -